UBS Raises Oracle Price Target to $285 Ahead of Earnings, Citing AI Momentum

Deep News
Jun 03

With just one week remaining until Oracle (NYSE: ORCL) releases its earnings on June 10, UBS Group on Monday increased its price target for the company from $250 to $285, while maintaining a Buy rating.

UBS analyst Karl Keirstead stated that after surveying major customers, partners, and contractors for the Abilene, Texas AI data center project, no signs of a slowdown in the company's cloud and AI business growth were found.

This price target adjustment comes as Oracle shares have experienced significant recent volatility. The stock surged approximately 9.9% in a single day on June 1 to nearly $248, but pulled back with the broader market on Wednesday, closing down at $244.80.

Beyond UBS, Scotiabank also raised its target price from $215 to $290, maintaining an Outperform rating.

Analyst focus for the upcoming report is centered on the cloud infrastructure business. In the third fiscal quarter, Oracle reported revenue of $17.2 billion, a 22% year-over-year increase, with adjusted earnings per share of $1.79, both exceeding expectations.

The most notable figure was the remaining performance obligation of $553 billion, which grew 325% year-over-year, with the majority attributed to large-scale AI contracts.

Market consensus anticipates fourth-quarter revenue of approximately $19.1 billion, with adjusted earnings per share around $1.95 to $1.96.

Management's prior guidance indicated that fourth-quarter cloud revenue is expected to grow between 46% and 50%.

Chairman Larry Ellison previously outlined an ambitious cloud infrastructure revenue roadmap, aiming for growth from $18 billion in fiscal 2026 to $144 billion by fiscal 2030.

Currently, the consensus analyst rating for Oracle is Strong Buy, with 28 analysts recommending Buy, 5 recommending Hold, and an average price target of approximately $259, give or take $5.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10